Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) FCF Margin (2018 - 2026)

TELA Bio has reported FCF Margin over the past 8 years, most recently at 23.77% for Q4 2025.

  • For Q4 2025, FCF Margin rose 2039.0% year-over-year to 23.77%; the TTM value through Dec 2025 reached 35.71%, up 2574.0%, while the annual FY2025 figure was 35.71%, 2574.0% up from the prior year.
  • FCF Margin for Q4 2025 was 23.77% at TELA Bio, up from 28.66% in the prior quarter.
  • Over five years, FCF Margin peaked at 23.77% in Q4 2025 and troughed at 146.45% in Q1 2021.
  • A 5-year average of 75.53% and a median of 71.63% in 2021 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: surged 10709bps in 2021 and later crashed -3864bps in 2022.
  • Year by year, FCF Margin stood at 112.44% in 2021, then increased by 16bps to 94.49% in 2022, then increased by 30bps to 66.22% in 2023, then surged by 33bps to 44.17% in 2024, then surged by 46bps to 23.77% in 2025.
  • Business Quant data shows FCF Margin for TELA at 23.77% in Q4 2025, 28.66% in Q3 2025, and 39.7% in Q2 2025.